Tag Archives: cov

Covidien Q1 Earnings Beat Estimates; Stock Hits High

Medical products maker Covidien (COV) beat fiscal Q1 expectations Friday morning, sending its stock up 5% to a new high on the stock market today. Covidien’s revenue rose 3% over the year-earlier quarter to $2.64 billion, beating analysts’ consensus by about $40 million. Profit excluding special items also rose 3% to $1 a share, 6 cents above estimates. The company raised its tax-rate guidance for fiscal 2014 (which ends in September) to

Covidien Expands In GI Market With Given Imaging

Covidien (COV) stock edged up Monday after the company on Sunday announced its third acquisition in little more than two years that expands its presence in the market for treating gastrointestinal, or GI, ailments. Ireland-based Covidien said it would buy Israel-based Given Imaging (GIVN) for $860 million, or $30 a share. That’s 27% above Given’s closing price Friday, and the lightly traded Given stock was up more than 25%, near 29.75, in morning